For the quarter ending 2026-03-31, ONCY has $8,161K in assets. $13,291K in debts. $5,493K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,493 | 5,202 | ||
| Other receivables | 961 | 573 | ||
| Prepaid expenses | 1,033 | 1,069 | ||
| Total current assets | 7,487 | 6,844 | ||
| Property and equipment, net | 218 | 228 | ||
| Right-of-use assets | 456 | 510 | ||
| Total assets | 8,161 | 7,582 | ||
| Accounts payable | 2,681 | 3,504 | ||
| Accrued liabilities | 2,576 | 2,327 | ||
| Other liabilities | - | 0 | ||
| Operating lease liabilities, current | 166 | 193 | ||
| Warrant derivative | 0 | 77 | ||
| Total current liabilities | 5,423 | 6,101 | ||
| Contract liability | 4,910 | 4,910 | ||
| Operating lease liabilities, non-current | 342 | 370 | ||
| Stock option liability | 2,616 | - | ||
| Total liabilities | 13,291 | 11,381 | ||
| Common shares, no par value unlimited shares authorized as of december31, 2025 and 2024 108,021,271 and 80,020,131 shares issued and outstanding as of december31, 2025 and 2024, respectively | - | 0 | ||
| Additional paid-in capital | 427,383 | 419,471 | ||
| Accumulated other comprehensive income | 6,225 | 6,225 | ||
| Accumulated deficit | -438,738 | -429,495 | ||
| Total stockholders deficit | -5,130 | -3,799 | ||
| Total liabilities and stockholders' deficit | 8,161 | 7,582 | ||
ONCOLYTICS BIOTECH INC (ONCY)
ONCOLYTICS BIOTECH INC (ONCY)